Corresponding Author: Lijuan Chen

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu (China)


In the article “SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell Lines” [Cell Physiol Biochem 2018;47:489-504; DOI: 10.1159/000489983] by Yan et al., due to errors during data processing, in Figure 2 the authors inadvertently used the images of 2.5mg/kg kidney and liver groups for the 10mg/kg group.

The corrected Figure 2 is shown here.

Fig. 2. Histopathological changes of A2780 xenograft models treated with SKLB060, PTX, and PMC6827.